Studies have reported that the increase in BCAT1 enzyme levels is associated with tumor growth and proliferation in various cancers, and inhibiting it in certain cases, such as glioblastoma, leads to a decrease in tumor development (45–47). This evidence concerns the gene BCAT1 and neoplasm.